Thyroid Cancer Coverage from Every Angle
Advertisement
Advertisement

Enrique Grande, MD, PhD, on Targeted Treatment for Thyroid Cancer

Posted: Thursday, March 12, 2020

Enrique Grande, MD, PhD, of MD Anderson Cancer Center, Madrid, discusses the significance of recent findings that showed the efficacy of selpercatinib in RET fusion–positive thyroid cancer and the importance of genetic testing in patients with the malignancy.

Advertisement
Advertisement


By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.